Clinical trials
Major Depressive Disorder trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 12 |
| 2021 | 8 |
| 2022 | 12 |
| 2023 | 12 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 76 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Mental Health Center | 21 |
| Changping Laboratory | 8 |
| Central South University | 3 |
| Guangzhou Psychiatric Hospital | 3 |
| The Third Affiliated hospital of Zhejiang Chinese Medical University | 3 |
| Tianjin Anding Hospital | 3 |
| Peking University | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University | 2 |
| Tianjin Medical University General Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 76 |
| Bipolar Disorder | 8 |
| Depressive Disorder, Treatment-Resistant | 8 |
| Depressive Disorder | 3 |
| Anxiety Disorders | 2 |
| Disease | 2 |
| Generalized Anxiety Disorder | 2 |
| Schizophrenia | 2 |
| Alzheimer Disease | 1 |
| Anhedonia | 1 |
Trials
Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.